The case, centered on Roche’s high-priced drug risdiplam used to treat Spinal Muscular Atrophy (SMA), brought public health and drug affordability to the forefront of the legal discourse. Justice Mini Pushkarna, delivering the verdict on March 24, underscored the primacy of public health in patent litigation involving critical medications. “Public health is not something that […]
With plastic pollution reaching critical levels, a growing number of innovators and companies are racing to develop sustainable alternatives. A new patent landscape analysis from Questel, led by chemistry specialist and business intelligence consultant Donia Ben Zakour, offers a comprehensive look into the evolving world of biodegradable plastics—and the findings suggest a wave of green
China’s National Intellectual Property Administration (CNIPA) released new statistics on April 15, 2025, revealing a significant decline in invention patent grants during the first quarter of the year. According to the official data, the number of invention patents granted between January and March 2025 dropped by 20.99% year-on-year, amounting to a reduction of 52,870 patents,
In a move that promises to bring greater efficiency to the U.S. patent system, the United States Patent and Trademark Office (USPTO) has announced a major update to its patent issuance process. This improvement marks a significant shift in the patenting landscape, providing faster legal recognition of inventions and reducing administrative lag for both individual
Tata Motors, India’s leading automotive manufacturer, announced on Thursday that it has achieved a record-breaking milestone in intellectual property filings, with 250 patents and 148 design applications submitted during FY2024-25, the highest in the company’s history for a single financial year. In a statement highlighting its innovation-driven strategy, Tata Motors emphasized that these filings span
Astellas Pharma, alongside the Regents of the University of California, has secured a major legal victory in Germany as the Federal Patent Court rejected a nullity suit challenging one of its key intellectual property rights protecting the blockbuster prostate cancer treatment Xtandi. The decision strengthens Astellas’ position as it continues to defend its IP portfolio
Shares of Indian pharmaceutical giants Lupin and Zydus Lifesciences came under significant selling pressure on April 16, falling by 3% and 4.5% respectively. The decline followed a ruling by the U.S. District Court in Delaware in favor of Astellas Pharma, the original patent holder of Myrbetriq, a drug used to treat overactive bladder (OAB). The
A newly published patent hints at a bold innovation that could define the Pixel 10 Pro: a touch-sensitive rear panel that recognizes gestures, expanding how users interact with their smartphones beyond the traditional touchscreen. Filed with the World Intellectual Property Organization (WIPO), the patent, titled “Leveraging Inactive Touchpoints For Gesture Recognition and User Interface Configuration,”
In a cryptic yet explosive post on X, Twitter co-founder Jack Dorsey called for the wholesale abolition of intellectual property law, declaring simply: “delete all IP law.” The message, posted without explanation or context, quickly drew a wave of attention — and an immediate show of support from Elon Musk, who replied in agreement. While
Peraso Inc., a leading innovator in millimeter-wave (mmWave) wireless technology, has announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application 17/846275, titled “System for Seamless Recovery of Distributed Access Points in a Wireless Local Area Network.” The patent is expected to be formally
